-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, CSwnR2I/zmYKA+G0Eh1GtROWDlQHOWA/QZsMDONRg3zG/unQxHgfwVr7EK1jK5Jv XYLRzSJ/NCfumeCZlbmXFA== 0001069308-09-000002.txt : 20090427 0001069308-09-000002.hdr.sgml : 20090427 20090427121653 ACCESSION NUMBER: 0001069308-09-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20090427 DATE AS OF CHANGE: 20090427 EFFECTIVENESS DATE: 20090427 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Opexa Therapeutics, Inc. CENTRAL INDEX KEY: 0001069308 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 760333165 STATE OF INCORPORATION: TX FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-70270 FILM NUMBER: 09771757 BUSINESS ADDRESS: STREET 1: 2635 N. CRESCENT RIDGE DRIVE CITY: THE WOODLANDS STATE: TX ZIP: 77381 BUSINESS PHONE: (281) 272-9331 MAIL ADDRESS: STREET 1: 2635 N. CRESCENT RIDGE DRIVE CITY: THE WOODLANDS STATE: TX ZIP: 77381 FORMER COMPANY: FORMER CONFORMED NAME: PharmaFrontiers Corp. DATE OF NAME CHANGE: 20051011 FORMER COMPANY: FORMER CONFORMED NAME: PHARMAFRONTIERS CORP DATE OF NAME CHANGE: 20040816 FORMER COMPANY: FORMER CONFORMED NAME: SPORTAN UNITED INDUSTRIES INC DATE OF NAME CHANGE: 19990305 D 1 primary_doc.xml X0301 D LIVE 0001069308 Opexa Therapeutics, Inc. 2635 N. CRESCENT RIDGE DRIVE THE WOODLANDS TX 77381 (281) 272-9331 PharmaFrontiers Corp. PHARMAFRONTIERS CORP SPORTAN UNITED INDUSTRIES INC TX Corporation true Neil K. Warma 2635 N. Crescent Ridge Drive The Woodlands TX 77381 Executive Officer David Hung 2635 N. Crescent Ridge Drive The Woodlands TX 77381 Director David B. McWilliams 2635 N. Crescent Ridge Drive The Woodlands TX 77381 Director David E. Jorden 2635 N. Crescent Ridge Drive The Woodlands TX 77381 Director Michael S. Richman 2635 N. Crescent Ridge Drive The Woodlands TX 77381 Director Scott B. Seaman 2635 N. Crescent Ridge Drive The Woodlands TX 77381 Director Biotechnology No Revenues 06 false 2009-04-14 false true Offering was for Issuer's Units. Each Unit consists of (A) $10,000 convertible note, convertible into 15,000 shs of Issuer's common stock at $0.75 p/share & (B) Series G Warrant to purchase 10,000 shs of Issuer's common stock at $0.50 p/share. false 1000 Cambria Capital, LLC 133760 None None 66 Exchange Place Suite 200 Salt Lake City UT 84111 CA CT NY OK UT 2000000 1101000 899000 For the purposes of this Form D, a market value of $10,000 per Unit of the Company ("Unit") was assigned to each Unit sold to offerees pursuant to this private offering. false 28 41600 0 As additional consideration, Cambria Capital, LLC received a Series G Warrant to purchase 87,360 shares of Common Stock of Opexa Therapeutics, Inc. at an exercise price of $0.50 per share. 0 false Opexa Therapeutics, Inc. /s/ Neil K. Warma Neil K. Warma President & CEO 2009-04-27 -----END PRIVACY-ENHANCED MESSAGE-----